SYNTHESIS AND HERBICIDAL AND ANTIOXIDANT ACTIVITY
713
Synthesis of (2,2-dimethyl-1,3-dioxolan-4-yl)me-
thyl morpholin-4-ylacetate (2), (2,2-dimethyl-1,3-
dioxolan-4-yl)methyl piperazin-1-ylacetate (3),
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl N,N-dieth-
ylglycinate (4), and bis[(2,2-dimethyl-1,3-dioxolan-
4-yl)methyl] 2,2'-(piperazine-1,4-diyl)diacetate (5)
(general procedure). To a mixture of 20 mL of acetoni-
trile and 0.15 mol (20.7 g) of K2CO3, we added 0.1 mol
of an amine: morpholine (8.7 g), piperazine (8.6 g), or
diethylamine (7.3 g). The mixture was refluxed for 2 h.
Then, 0.12 mol (20.8 g) of compound 1 was added, and
the mixture was refluxed for 7 h. The resulting mixture
was filtered while hot, and the filtrate was evaporated
and vacuum-distilled.
Bis[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]
2,2'-(piperazine-1,4-diyl)diacetate (5). Yield 57%,
1
Тm = 152–154°С. Н NMR spectrum, δ, ppm (J, Hz):
1.30 s (6H, 2C7H3), 1.39 s (6H, C6H3), 2.52 s (4H,
C1'H2, C1''H2), 3.20 s (4H, 2C10H2), 3.75 s (4H, C2'H2,
C2''H2), 3.71 m (1H, C4H1), 4.14 d (1H, C5Ha, 2J = 2.8),
2
4.27 d (1H, C5Hb, J = 2.8). 13C NMR spectrum, δС,
ppm: 25.73 (2C7H3), 26.94 (2C6H3), 52.45 (C2' + C2'',
C1' + C1''), 58.59 (C10), 64.69 (C8), 65.80 (C4), 73.49
(C5), 109.22 (C2), 170.15 (C9).
Synthesis of methyl piperazin-1-ylacetate (6) and
dimethyl 2,2'-(piperazine-1,4-diyl)diacetate (7) (gen-
eral procedure). A three-necked flask equipped with a
reflux condenser, a thermometer, and a mechanical stir-
rer was charged with 0.03 mol (2.58 g) of piperazine,
15 mL of DMSO, and 0.01 mol (2.08 g) of methyl mon-
ochloroacetate. The mixture was stirred for the required
time at 70–75°C. After the reaction completion, the mix-
ture was washed with a 20% NaOH solution and ex-
tracted with ether. The upper organic layer was washed
with water to neutral reaction and dried over anhydrous
potassium carbonate. The solvent was evaporated on a
rotary evaporator, and the residue was distilled under re-
duced pressure in a nitrogen flow.
(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl morpho-
lin-4-ylacetate (2). Yield 37%, Тb = 160°С (2 mmHg).
1Н NMR spectrum, δ, ppm (J, Hz): 1.30 s (3H, C7H3),
1.39 s (3H, C6H3), 2.52 s (4H, C3'H2, C3''H2), 3.20 s
(2H, C10H2), 3.75 s (4H, C2'H2, C2''H2), 3.70–3.74 m
2
(1H, C4H1), 4.14 d (1H, C5Ha, J = 2.8), 4.26 d (1H,
2
C5Hb, J = 2.8). 13C NMR spectrum, δС, ppm: 25.23
(C7), 26.57 (C6), 53.14 (C3' + C3''), 59.21 (C10H2), 64.52
(C8H2), 64.71 (C5H2), 66.10 (C2' + C2''), 73.72 (C4H1)
109.77 (C2), 169.77 (C9). Mass spectrum, m/e (Irel, %):
[M]+ 259 (1), 193 (50), 101 (24), 77 (24), 72 (14), 57
(20), 43 (100).
Methyl piperazin-1-ylacetate (6). Yield 48%, Тm =
1
122–124°С. Н NMR spectrum, δ, ppm (J, Hz): 2.51 s
(1H, NH), 2.63 s (8H, C4H2, C4'H2, C5H2, C5'H2), 3.36 s
(2H, C1H2), 3.69 s (3H, C3H3). 13C NMR spectrum, δС,
ppm: 47.01 (C5 + C5'), 52.13 (C3), 54.10 (C1), 57.32
(C4 + C4'), 176.71 (C2). Mass spectrum, m/e (Irel, %):
[M]+ 158 (8), 116 (20), 99 (100), 88 (8), 70 (18), 56 (34).
(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl
piper-
azin-1-ylacetate (3). Yield 31%, Тm = 135–137°С.
1Н NMR spectrum, δ, ppm (J, Hz): 1.32 s (3H, C7H3),
1.38 s (3H, C6H3), 2.31 s (1H, NH), 2.53 s (4H, C2'H2,
C2''H2), 3.11 s (4H, 2CH2), 3.20 s (2H, C10H2), 3.72 m
Dimethyl 2,2'-(piperazin-1,4-diyl)diacetate (7).
Yield 70%, Тm = 134–136°С. 1Н NMR spectrum, δ, ppm
(J, Hz): 2.65 s (8H, C4H2, C4'H2, C5H2, C5'H2), 3.25 s
(4H, 2C1H2), 3.71 s (6H, 2C3H3). 13C NMR spectrum,
δС, ppm: 51.73 (2C3), 52.76 (C4 + C4', C5 + C5'), 59.33
(2C1), 170.65 (2C2). Mass spectrum, m/e (Irel, %): [M]+
230 (10), 171 (100), 98 (58), 80 (8) 70 (12), 56 (28).
2
(1H, C4H1), 4.02 d (2H, C8H2, J = 4.1), 4.15-4.25 d.d
2
3
13
(2H, C5H2, J = 7.8, J = 4.6). C NMR spectrum, δС,
ppm: 25.41 (C7), 26.35 (C6), 46.91 (C3' + C3''), 55.74
(C2' + C2''), 56.22 (C10), 64.10 (C8), 64.46 (C5), 73.70
(C4), 107.97 (C2), 173.01 (C9).
(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl N,N-di-
ethylglycinate (4). Yield 58%, Тb = 142°С (5 mmHg).
1Н NMR spectrum, δ, ppm (J, Hz): 1.05 t (6H, 2C13H3,
2J = 7.2), 1.31 s (3H, C7H3), 1.39 s (3H, C6H3), 2.61 q
(4H, 2C11H2, 2J = 7.1), 3.32 s (2H, C10H2), 3.71 m (1H,
C4H1), 4.05 d (1H, C5Hb, 2J = 6.0), 4.15 d.d (2H, C8H2,
2J = 4.3, 3J = 7.1), 4.29 d (1H, C5Ha, 2J = 6.0). 13C NMR
spectrum, δС, ppm: 12.08 (2C12), 25.31 (C7), 26.65 (C6),
47.66 (2C11), 53.73 (C10), 64.58 (C8), 65.80 (C5), 73.50
(C4), 109.82 (C2), 171.12 (C9). Mass spectrum, m/e (Irel,
%): [M]+ 245 (2), 230 (6.5), 86 (100), 43 (10).
Synthesis of (2,2-dimethyl-1,3-dioxolan-4-yl)
methyl N-benzyl-N-[(2,2-dichlorocyclopropyl)me-
thyl]glycinate (8) and methyl N-benzyl-N-[(2,2-
dichlorocyclopropyl)methyl]glycinate (9) (general
procedure). To a mixture of 20 mL of acetonitrile and
0.15 mol (20.7 g) of K2CO3, we added 0.1 mol (23 g) of
N-benzyl-1-(2,2-dichlorocyclopropyl)methanamine and
0.12 mol (24.9 g) of (2,2-dimethyl-1,3-dioxolan-4-yl)
methyl chloroacetate (1) or 0.12 mol (12.9 g) of methyl
chloroacetate. The mixture was stirred under microwave
RUSSIAN JOURNAL OF APPLIED CHEMISTRY Vol. 93 No. 5 2020